News Kayentis raises €7m for its digital trial engagement platfor... French tech company Kayentis has raised €7 million in private funding that will be invested in its digital platform for clinical trials.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face